Cargando…

Conclusiveness of the Cochrane Eye and Vision Group Reviews

BACKGROUND: To assess the conclusiveness of Cochrane Eye and Vision Group Reviews (EVGRs). We tested the hypotheses that: (1) the majority of EVGRs are inconclusive; (2) most reviews state the need for further and better studies; (3) the conclusiveness of a given review is affected by the number of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mimouni, Michael, Mimouni, Francis, Segev, Fani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468979/
https://www.ncbi.nlm.nih.gov/pubmed/26076817
http://dx.doi.org/10.1186/s13104-015-1221-x
_version_ 1782376577602945024
author Mimouni, Michael
Mimouni, Francis
Segev, Fani
author_facet Mimouni, Michael
Mimouni, Francis
Segev, Fani
author_sort Mimouni, Michael
collection PubMed
description BACKGROUND: To assess the conclusiveness of Cochrane Eye and Vision Group Reviews (EVGRs). We tested the hypotheses that: (1) the majority of EVGRs are inconclusive; (2) most reviews state the need for further and better studies; (3) the conclusiveness of a given review is affected by the number of randomized controlled trials (RCTs) included and the cumulative number of patients and eyes studied. METHODS: A retrospective study of all EVGRs available in the Cochrane Library in June 2013. For each EVGR we recorded the number of RCTs found by the reviewers, the number of RCTs included for final analysis as fulfilling inclusion criteria, the total cumulative number of patients and eyes studied, the stated need for further and better studies, the reason stated for further studies and the type of conclusion reached by the reviewer(s). We used the Kruskal–Wallis test to determine differences between ‘‘conclusive’’ and ‘‘inconclusive’’ studies in terms of the outcome variables studied. The correlation between the number of included studies and cumulative sample size was studied using regression analysis. RESULTS: Out of 106 EVGRs, 52.8% were conclusive. In 83.9% of the conclusive EVGRs one treatment/strategy/drug was found to be better than the alternative. The average number of available and included RCTs was significantly higher in conclusive EVGRs (P = 0.007 and P = 0.003 respectively). The total cumulative number of patients and number of eyes studied was approximately ten times higher in the conclusive EVGRs (P < 0.001 and P < 0.015 respectively). A similar percentage of RCTs was included in both conclusive and inconclusive reviews (76 vs. 73%). The vast majority of EVGRs, whether conclusive (84%) or inconclusive (96%), stated the need for further and better studies (P = 0.042). Fifty eight percent of the EVGRs justified the need for further studies for at least two reasons. The reason that was stated the most was a need for a larger amount of RCTs (67%). CONCLUSIONS: In approximately half of the cases, EVGRs allow the reader to reach a clinically applicable conclusion. Larger total cumulative participants, total cumulative number of eyes studied and number of RCTs performed all increase the likelihood of an EVGR to be conclusive.
format Online
Article
Text
id pubmed-4468979
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44689792015-06-17 Conclusiveness of the Cochrane Eye and Vision Group Reviews Mimouni, Michael Mimouni, Francis Segev, Fani BMC Res Notes Research Article BACKGROUND: To assess the conclusiveness of Cochrane Eye and Vision Group Reviews (EVGRs). We tested the hypotheses that: (1) the majority of EVGRs are inconclusive; (2) most reviews state the need for further and better studies; (3) the conclusiveness of a given review is affected by the number of randomized controlled trials (RCTs) included and the cumulative number of patients and eyes studied. METHODS: A retrospective study of all EVGRs available in the Cochrane Library in June 2013. For each EVGR we recorded the number of RCTs found by the reviewers, the number of RCTs included for final analysis as fulfilling inclusion criteria, the total cumulative number of patients and eyes studied, the stated need for further and better studies, the reason stated for further studies and the type of conclusion reached by the reviewer(s). We used the Kruskal–Wallis test to determine differences between ‘‘conclusive’’ and ‘‘inconclusive’’ studies in terms of the outcome variables studied. The correlation between the number of included studies and cumulative sample size was studied using regression analysis. RESULTS: Out of 106 EVGRs, 52.8% were conclusive. In 83.9% of the conclusive EVGRs one treatment/strategy/drug was found to be better than the alternative. The average number of available and included RCTs was significantly higher in conclusive EVGRs (P = 0.007 and P = 0.003 respectively). The total cumulative number of patients and number of eyes studied was approximately ten times higher in the conclusive EVGRs (P < 0.001 and P < 0.015 respectively). A similar percentage of RCTs was included in both conclusive and inconclusive reviews (76 vs. 73%). The vast majority of EVGRs, whether conclusive (84%) or inconclusive (96%), stated the need for further and better studies (P = 0.042). Fifty eight percent of the EVGRs justified the need for further studies for at least two reasons. The reason that was stated the most was a need for a larger amount of RCTs (67%). CONCLUSIONS: In approximately half of the cases, EVGRs allow the reader to reach a clinically applicable conclusion. Larger total cumulative participants, total cumulative number of eyes studied and number of RCTs performed all increase the likelihood of an EVGR to be conclusive. BioMed Central 2015-06-16 /pmc/articles/PMC4468979/ /pubmed/26076817 http://dx.doi.org/10.1186/s13104-015-1221-x Text en © Mimouni et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Mimouni, Michael
Mimouni, Francis
Segev, Fani
Conclusiveness of the Cochrane Eye and Vision Group Reviews
title Conclusiveness of the Cochrane Eye and Vision Group Reviews
title_full Conclusiveness of the Cochrane Eye and Vision Group Reviews
title_fullStr Conclusiveness of the Cochrane Eye and Vision Group Reviews
title_full_unstemmed Conclusiveness of the Cochrane Eye and Vision Group Reviews
title_short Conclusiveness of the Cochrane Eye and Vision Group Reviews
title_sort conclusiveness of the cochrane eye and vision group reviews
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468979/
https://www.ncbi.nlm.nih.gov/pubmed/26076817
http://dx.doi.org/10.1186/s13104-015-1221-x
work_keys_str_mv AT mimounimichael conclusivenessofthecochraneeyeandvisiongroupreviews
AT mimounifrancis conclusivenessofthecochraneeyeandvisiongroupreviews
AT segevfani conclusivenessofthecochraneeyeandvisiongroupreviews